Vascular Medicine is a premier academic journal for researchers and practitioners in the field of cardiovascular health, published by SAGE Publications Ltd. With an ISSN of 1358-863X and E-ISSN 1477-0377, this esteemed journal has been at the forefront of publishing quality research since its inception in 1992, with convergence extending to 2024. Ranked in the Q2 category for both Cardiology and Cardiovascular Medicine as well as for miscellaneous Medicine in 2023, it is recognized for its significant contributions to advancing knowledge and clinical practice within these domains. Its Scopus ranking situates it at #91 out of 387 in the field, reflecting its high impact and the relevance of its published research, which is crucial for addressing the challenges in vascular health today. Although it is not an open-access journal, Vascular Medicine remains dedicated to disseminating vital findings that bridge the gap between research and clinical application, making it an essential resource for medical researchers, healthcare professionals, and students alike.

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, published by Lippincott Williams & Wilkins, is a leading journal in the field of cardiovascular medicine, dedicated to the advancement of research surrounding arterial diseases, thrombosis, and vascular biology. With an impressive impact factor indicative of its reach and influence, this journal occupies a prominent position in the Q1 category of cardiology, ranking 13th out of 387 in its field according to Scopus, placing it within the top 96th percentile among cardiovascular research journals. Since its inception in 1990, ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY has been pivotal in disseminating cutting-edge research that drives innovation and education in cardiovascular health. Although it does not operate under an open access model, the journal is a vital resource for researchers, clinicians, and students looking for high-quality, peer-reviewed articles that contribute to the understanding and treatment of cardiovascular and vascular disorders. Its commitment to rigorous scientific standards and its focus on impactful findings make it an essential publication for anyone dedicated to the field.

Welcome to the International Journal of Angiology, a distinguished publication dedicated to advancing the field of cardiology and cardiovascular medicine. Published by THIEME MEDICAL PUBL INC, this journal plays a crucial role in disseminating innovative research and clinical insights from 1992 through 2024, serving as a vital resource for researchers, healthcare professionals, and students alike. With an ISSN of 1061-1711 and an E-ISSN of 1615-5939, the journal currently holds a respectable Q4 ranking in the cardiology field, reflecting its commitment to quality and relevance. Although it operates under a traditional access model, the journal ensures that critical research findings are shared with a broad audience, fostering collaboration and knowledge exchange. By exploring current trends, diagnostic techniques, and treatment modalities in angiology, the International Journal of Angiology remains an essential platform for those dedicated to improving cardiovascular health around the globe.

Microvascular Research is a prominent journal dedicated to advancing the understanding of microvascular biology and its implications in various health and disease contexts. Published by Academic Press Inc elsevier Science, this journal holds a significant place in the academic community with an impact factor reflecting its high citation frequency and relevance within its fields. With a Q2 ranking in both Biochemistry and Cardiology and Cardiovascular Medicine, as well as a Q3 ranking in Cell Biology, it provides an essential platform for researchers and professionals to publish and access groundbreaking studies. Established in 1968 and running through to 2025, Microvascular Research covers a broad scope, focusing on various topics related to microvessels and their functions, emphasizing the importance of these structures in health and pathology. Although the journal does not offer open access, it remains a vital resource for those seeking to deepen their understanding of microvascular dynamics, making it an essential addition to the libraries of researchers, clinicians, and students alike.

Current Atherosclerosis Reports, published by CURRENT MEDICINE GROUP, is a leading scientific journal in the field of Cardiology and Cardiovascular Medicine, boasting an impressive Q1 ranking in its category as of 2023. This esteemed journal, with an ISSN of 1523-3804 and an E-ISSN of 1534-6242, has been a cornerstone of cardiovascular research since its inception in 1999, continuing to publish cutting-edge studies through 2024. With unparalleled insights into the mechanisms, prevention, and treatment of atherosclerosis, it serves as an essential resource for researchers, healthcare professionals, and students alike. Although not an open-access journal, it is highly regarded within the academic community, highlighted by its Scopus rank of #54 out of 387 in its field, placing it in the 86th percentile. The journal's commitment to advancing knowledge in cardiovascular health underscores its integral role in guiding clinical practices and influencing future research directions.

Seminars in Vascular Surgery is a premier academic journal dedicated to advancing the field of vascular surgery and related cardiovascular medicine. Published by W B Saunders Co-Elsevier Inc., this journal boasts a commendable reputation within the academic community, evidenced by its classification in the Q1 quartile for both Cardiology and Cardiovascular Medicine and Surgery as of 2023. It serves as a critical resource for researchers, clinicians, and students, providing high-quality, peer-reviewed articles that cover the latest advancements, techniques, and interdisciplinary approaches in vascular surgery. With an ISSN of 0895-7967 and an E-ISSN of 1558-4518, the journal is poised to offer an invaluable platform for scholarship, with a varied scope reflecting decades of research from 1990 to 2024. By submitting your work, you join a cohort of scholars dedicated to elevating the standards of vascular surgical practice and improving patient outcomes.

EJVES Vascular Forum, published by Elsevier, is a premier open access journal focusing on the interdisciplinary field of vascular surgery and cardiovascular medicine. Since its inception in 2001, the journal has provided a vital platform for the dissemination of high-quality research and innovative clinical practices, addressing critical issues in vascular health. With an ISSN of 2666-688X, it has gained recognition within its community, attaining a Q3 quartile ranking in both cardiology and surgery categories as of 2023, and showcasing its relevance and impact within the medical research landscape. Situated in the United Kingdom and accessible globally, the EJVES Vascular Forum invites contributions that foster collaboration and enhance knowledge in vascular surgery, making it an essential resource for researchers, professionals, and students alike. The journal's ranking within Scopus highlights its position among peers, adding further credence to its objectives of advancing science and improving patient care in the cardiovascular realm. By publishing rigorously peer-reviewed articles, the journal aims to be the go-to source of information and innovation for those dedicated to the progress of vascular health.

Vascular and Endovascular Surgery is a distinguished peer-reviewed journal dedicated to the advancements and innovations in the field of vascular and endovascular medicine. Published by SAGE Publications Inc, this journal serves as a vital platform for clinicians, researchers, and students keen to explore cutting-edge practices, surgical techniques, and emerging therapies within cardiovascular medicine. With an ISSN of 1538-5744 and an E-ISSN of 1938-9116, it has established a solid reputation since its inception, covering articles from its founding years in 1967 to its continuous releases up to 2024. The journal currently holds a Q3 quartile ranking in the categories of Cardiology and Cardiovascular Medicine and Surgery, highlighting its significance within the academic community. Although it is not an open-access journal, it offers valuable content that supports evidence-based practice and clinical decisions in vascular and endovascular procedures. By embracing multidisciplinary collaboration and fostering innovation, Vascular and Endovascular Surgery remains a critical resource for those invested in enhancing patient outcomes and advancing surgical methodologies.

Diabetes & Vascular Disease Research is a leading academic journal dedicated to advancing the understanding and treatment of cardiovascular and metabolic diseases, particularly diabetes. Published by SAGE Publications Ltd in the United Kingdom, this journal serves as a key resource for researchers, clinicians, and students seeking to explore the intricate relationship between diabetes and vascular health. With an impressive Impact Factor and ranked in the Q2 quartile in prominent categories such as Cardiology, Endocrinology, and Internal Medicine, the journal provides a platform for high-quality, peer-reviewed research. Covering a broad range of topics from pathophysiology to therapeutic innovations, Diabetes & Vascular Disease Research plays a vital role in shaping contemporary discourse in the field. With contributions from leading experts and a commitment to disseminating valuable findings, this journal is a must-read for anyone involved in the fight against vascular complications arising from diabetes.

Artery Research is an esteemed open access journal published by BMC in the United Kingdom, dedicated to advancing the field of vascular biology and cardiovascular medicine. Since its inception in 2006 and transitioning to an open access format in 2019, the journal has become a pivotal platform for disseminating high-quality research on arterial health, pathology, and the latest clinical advancements. With an impactful focus on anatomy, cardiology, and physiology, Artery Research holds a notable reputation within the global research community, ranked in the Q3 and Q4 category quartiles in its respective fields and reflected in its Scopus ranks. The journal aims to foster collaborations and discussions among researchers and practitioners by providing an accessible avenue for publishing pivotal findings and insights. As it continues to evolve through 2024 and beyond, Artery Research remains committed to enriching cardiovascular research and driving innovations toward better health outcomes.